FDA Approves First Gene Therapy for Pediatric Sickle Cell Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted approval for the first gene therapy technology intended to treat sickle cell disease in children. This milestone represents a notable development in the field of pediatric hematology, offering a new therapeutic approach for patients who have historically relied on symptom